Literature DB >> 6944150

Cytogenetic follow-up in chronic myeloid leukemia.

S E Hartley, S McBeath.   

Abstract

Twenty-six patients with Philadelphia chromosome (Ph1)-positive chronic myeloid leukaemia have been followed-up cytogenetically. Twelve patients were found to have chromosome abnormalities in addition to the Ph1, either in the chronic phase or during progression of disease. The most common abnormality observed was an additional chromosome No. 19 although trisomy 8, a second Ph1 and isochromosome 17 were also observed.

Entities:  

Mesh：

Year:  1981        PMID： 6944150     DOI： 10.1016/0165-4608(81)90054-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  5 in total

1.  Sequence of the intercistronic region between the ribulose-1, 5-bisphosphate carboxylase/oxygenase large subunit and coupling factor beta subunit gene.

Authors:  K Shinozaki; M Sugiura
Journal:  Nucleic Acids Res       Date:  1982-08-25       Impact factor: 16.971

2.  Nucleotide sequence of the gene for the M(r) 32,000 thylakoid membrane protein from Spinacia oleracea and Nicotiana debneyi predicts a totally conserved primary translation product of M(r) 38,950.

Authors:  G Zurawski; H J Bohnert; P R Whitfeld; W Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  In vitro expression and characterization of the translation start site of the psbA gene product (QB protein) from higher plants.

Authors:  B N Cohen; T A Coleman; J J Schmitt; H Weissbach
Journal:  Nucleic Acids Res       Date:  1984-08-10       Impact factor: 16.971

4.  Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression.

Authors:  Richard E Clark; Jane F Apperley; Mhairi Copland; Silvia Cicconi
Journal:  Blood Adv       Date:  2021-02-23

5.  DNA sequence requirements for the accurate transcription of a protein-coding plastid gene in a plastid in vitro system from mustard (Sinapis alba L.).

Authors:  G Link
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.